Bennett C, Voss LJ, Barnard JP, Sleigh JW Practical use of the raw electroencephalogram waveform during general anesthesia: the art and science. Anesth Analg. 2009 Aug;109(2):539-50. doi: 10.1213/ane.0b013e3181a9fc38. Review.
Brown EN, Purdon PL The aging brain and anesthesia. Curr Opin Anaesthesiol. 2013 Aug;26(4):414-9. doi: 10.1097/ACO.0b013e328362d183. Review.
Hayashi K, Indo K, Sawa T Anaesthesia-dependent oscillatory EEG features in the super-elderly. Clin Neurophysiol. 2020 Sep;131(9):2150-2157. doi: 10.1016/j.clinph.2020.05.027. Epub 2020 Jun 23.
Otto KA, Cebotari S, Höffler HK, Tudorache I Electroencephalographic Narcotrend index, spectral edge frequency and median power frequency as guide to anaesthetic depth for cardiac surgery in laboratory sheep. Vet J. 2012 Mar;191(3):354-9. doi: 10.1016/j.tvjl.2011.02.023. Epub 2011 Mar 30.
Schultz A, Siedenberg M, Grouven U, Kneif T, Schultz B Comparison of Narcotrend Index, Bispectral Index, spectral and entropy parameters during induction of propofol-remifentanil anaesthesia. J Clin Monit Comput. 2008 Apr;22(2):103-11. doi: 10.1007/s10877-008-9111-6. Epub 2008 Feb 21.
Smith WD, Dutton RC, Smith NT Measuring the performance of anesthetic depth indicators. Anesthesiology. 1996 Jan;84(1):38-51. Review.
Study on the Influencing Factors of Electroencephalogram Parameters Under Anesthesia
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
